Day One Biopharmaceuticals, Inc.
DAWN$972M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBRISBANE184 employees
Drugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Q2 2027
Market Overview
Stock performance and key metrics
DAWN News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Chemotherapeutic Agent | Phase 3 | Low-grade Glioma | - | - |
Tovorafenib | Phase 3 | Low-grade Glioma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply